An observational study in - Study Focus: Renal Retention of Lipid Microbubbles, sponsored by Oregon Health and Science University. Completed at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2016-04-28.
Sponsored by Oregon Health and Science University · Observational
Flank pain has been reported with ultrasound (US) contrast agents. The purpose of this study is to determine whether there is retention of ultrasound contrast agents in the renal microcirculation, which has been described in mice.
In this study patients undergoing clinically indicated contrast echocardiography will have renal ultrasound performed 10 minutes after completion of contrast infusion to determine the presence and location of renal retention of lipid microbubbles.
Oregon Health and Science University is the lead sponsor of 676 studies on the registry; 136 are open to participants now.
Of its 49 completed or terminated interventional studies of FDA-regulated products, 36 (73%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients undergoing contrast echocardoigraphy
Exclusion Criteria:
Patients undergoing contrast-enhanced echo.
Renal Video Intensity Units
Video intensity units in the kidney 10 min after completion of a clinically indicated contrast echocardiography study.
Time frame: 10 min
| Milestone | Contrast Administration |
|---|---|
| Started | 10 |
| Completed | 10 |
| Not completed | 0 |
Video intensity units in the kidney 10 min after completion of a clinically indicated contrast echocardiography study.
| units on a scale | Contrast Administration |
|---|---|
| Renal Video Intensity Units | 19 ± 9 |
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Contrast Administration | — | 0/10 (0%) | 0/10 (0%) |
Subjects undergoing contrast echo
| Age, Categorical(Participants) | Contrast Administration |
|---|---|
| <=18 years | 0 |
| Between 18 and 65 years | 8 |
| >=65 years | 2 |
| Sex: Female, Male(Participants) | Contrast Administration |
|---|---|
| Female | 4 |
| Male | 6 |
| Region of Enrollment(participants) | Contrast Administration |
|---|---|
| United States | 10 |
This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Oregon Health and Science University